More and more people realize that DPP-4 inhibitors may play a huge role in fighting COVID-19 combined with diabetes.[19–20] However, there is no evidence-based medicine to confirm the effectiveness and safety of DPP-4 inhibitors in the treatment of COVID-19 patients with diabetes. The gene discussed is DPP4; the disease is COVID-19.